Doximity (NASDAQ:DOCS) Price Target Raised to $75.00

Doximity (NASDAQ:DOCSFree Report) had its price target hoisted by Barclays from $52.00 to $75.00 in a research note published on Monday morning,Benzinga reports. They currently have an overweight rating on the stock.

A number of other brokerages have also commented on DOCS. Baird R W raised Doximity to a “strong-buy” rating in a research report on Tuesday, September 17th. Robert W. Baird upped their target price on shares of Doximity from $41.00 to $45.00 and gave the company an “outperform” rating in a research note on Tuesday, September 17th. Canaccord Genuity Group raised their price target on shares of Doximity from $37.00 to $40.00 and gave the stock a “buy” rating in a research note on Tuesday, August 20th. Bank of America lifted their price objective on Doximity from $32.00 to $45.00 and gave the company a “neutral” rating in a report on Monday, October 7th. Finally, Truist Financial restated a “hold” rating and set a $35.00 target price (up previously from $31.00) on shares of Doximity in a research report on Wednesday, August 14th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $45.69.

Read Our Latest Analysis on DOCS

Doximity Stock Down 2.2 %

DOCS stock opened at $59.93 on Monday. The business’s 50-day simple moving average is $42.04 and its 200 day simple moving average is $33.44. The company has a market cap of $11.13 billion, a PE ratio of 70.40, a price-to-earnings-growth ratio of 7.00 and a beta of 1.30. Doximity has a twelve month low of $22.96 and a twelve month high of $61.75.

Hedge Funds Weigh In On Doximity

Several institutional investors have recently modified their holdings of the business. First Horizon Advisors Inc. lifted its position in Doximity by 22.5% in the 3rd quarter. First Horizon Advisors Inc. now owns 2,094 shares of the company’s stock valued at $91,000 after acquiring an additional 384 shares in the last quarter. Commerce Bank acquired a new position in Doximity during the third quarter worth $314,000. Prospera Private Wealth LLC acquired a new stake in Doximity in the 3rd quarter valued at about $133,000. Thrivent Financial for Lutherans increased its holdings in shares of Doximity by 5.0% during the 3rd quarter. Thrivent Financial for Lutherans now owns 30,991 shares of the company’s stock worth $1,350,000 after acquiring an additional 1,474 shares during the last quarter. Finally, Natixis Advisors LLC boosted its holdings in shares of Doximity by 43.5% during the 3rd quarter. Natixis Advisors LLC now owns 31,815 shares of the company’s stock worth $1,386,000 after buying an additional 9,644 shares during the period. Institutional investors own 87.19% of the company’s stock.

Doximity Company Profile

(Get Free Report)

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Recommended Stories

Analyst Recommendations for Doximity (NASDAQ:DOCS)

Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.